Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Tianjin Pharmaceutical Da Ren Tang Group Corp. has approved the appointment of Ms. Xie Xi as a new member of the Supervisory Committee, succeeding Mr. Xing Jianhua, whose term is ending. Ms. Xie Xi brings extensive experience in finance and management, having served various roles within the company since 2008. Her appointment will be finalized pending shareholder approval at a forthcoming general meeting.
For further insights into SG:T14 stock, check out TipRanks’ Stock Analysis page.